Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Very early researchStudy completedNCT03358563
What this trial is testing

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Looking for participantsNCT06296706
What this trial is testing

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 630
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Post-approval studies (Phase 4)Study completedNCT00488904
What this trial is testing

Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery

Who this might be right for
Colorectal Cancer
Aalborg University Hospital 148
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Not applicableStudy completedNCT02823184
What this trial is testing

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
University Hospital, Bordeaux 148
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Early research (Phase 1)Active Not RecruitingNCT05878184
What this trial is testing

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

Who this might be right for
Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Sana Biotechnology 16
Early research (Phase 1)Study completedNCT00005633
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03013933
What this trial is testing

Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 29
Not applicableStudy completedNCT03305133
What this trial is testing

Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)

Who this might be right for
Large Cell Lung CancerNeuroendocrine Carcinoma of Lung (Diagnosis)
Groupe Francais De Pneumo-Cancerologie 86
Not applicableStudy completedNCT00013247
What this trial is testing

Facilitating Shared Decisionmaking About Prostate Cancer Screening

Who this might be right for
Prostate Cancer
US Department of Veterans Affairs 1,152
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Early research (Phase 1)Ended earlyNCT02919449
What this trial is testing

Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab

Who this might be right for
Recurrent Non-Small Cell Lung Cancer
Vyriad, Inc. 2
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Not applicableStudy completedNCT00330538
What this trial is testing

Osteoporosis in Children With ALL

Who this might be right for
Leukemia, Lymphocytic, Acute, L1
Children's Mercy Hospital Kansas City 20
Early research (Phase 1)Study completedNCT00992758
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 11
Next Page